Chemotherapy Related Anemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
This study is investigating darbepoetin alfa for the treatment of anemia in patients with non-myeloid cancers who are receiving chemotherapy. Darbepoetin alfa is a recombinant protein that stimulates the production of red blood cells. In this study, darbepoetin alfa will be administered as either an injection under the skin (subcutaneously) or directly into a vein (intravenously).
Epistemonikos ID: 857afe9997eadc111acd52d46f82f28b8289c71b
First added on: May 03, 2024